Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8547337rdf:typepubmed:Citationlld:pubmed
pubmed-article:8547337lifeskim:mentionsumls-concept:C0327577lld:lifeskim
pubmed-article:8547337lifeskim:mentionsumls-concept:C0040549lld:lifeskim
pubmed-article:8547337lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:8547337lifeskim:mentionsumls-concept:C2717775lld:lifeskim
pubmed-article:8547337lifeskim:mentionsumls-concept:C0037633lld:lifeskim
pubmed-article:8547337lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:8547337lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:8547337lifeskim:mentionsumls-concept:C1382100lld:lifeskim
pubmed-article:8547337lifeskim:mentionsumls-concept:C0450363lld:lifeskim
pubmed-article:8547337lifeskim:mentionsumls-concept:C0379703lld:lifeskim
pubmed-article:8547337pubmed:issue1lld:pubmed
pubmed-article:8547337pubmed:dateCreated1996-2-22lld:pubmed
pubmed-article:8547337pubmed:abstractTextThe solution conformation of a synthetic snake venom toxin waglerin I, has been determined by using proton nuclear magnetic resonance spectroscopy. By a combination of various two-dimensional NMR techniques, the 1H-NMR spectrum of waglerin I was completely assigned. A set of 247 interproton distance restraints was derived from nuclear Overhauser enhancement (NOE) measurements. These NOE constraints, in addition to the 2 dihedral angle restraints (from coupling constant measurements) and 7 omega torsion angel restraints for prolines, formed the basis of three-dimensional structure determined by molecular dynamics techniques. The 19 structures that were obtained satisfy the experimental restraints, and display small deviation from idealized covalent geometry. Analysis of converged structures indicates that the toxin has no special secondary structure. In the solution structure of waglerin I, the central ring region is well defined but the N- and C-termini possesses more disorder.lld:pubmed
pubmed-article:8547337pubmed:languageenglld:pubmed
pubmed-article:8547337pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8547337pubmed:citationSubsetIMlld:pubmed
pubmed-article:8547337pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8547337pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8547337pubmed:statusMEDLINElld:pubmed
pubmed-article:8547337pubmed:monthJanlld:pubmed
pubmed-article:8547337pubmed:issn0006-3002lld:pubmed
pubmed-article:8547337pubmed:authorpubmed-author:ChenCClld:pubmed
pubmed-article:8547337pubmed:authorpubmed-author:HuangT HTHlld:pubmed
pubmed-article:8547337pubmed:authorpubmed-author:WangK TKTlld:pubmed
pubmed-article:8547337pubmed:authorpubmed-author:WuS HSHlld:pubmed
pubmed-article:8547337pubmed:authorpubmed-author:ChuangL CLClld:pubmed
pubmed-article:8547337pubmed:authorpubmed-author:YuH MHMlld:pubmed
pubmed-article:8547337pubmed:issnTypePrintlld:pubmed
pubmed-article:8547337pubmed:day4lld:pubmed
pubmed-article:8547337pubmed:volume1292lld:pubmed
pubmed-article:8547337pubmed:ownerNLMlld:pubmed
pubmed-article:8547337pubmed:authorsCompleteYlld:pubmed
pubmed-article:8547337pubmed:pagination145-55lld:pubmed
pubmed-article:8547337pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8547337pubmed:meshHeadingpubmed-meshheading:8547337-...lld:pubmed
pubmed-article:8547337pubmed:meshHeadingpubmed-meshheading:8547337-...lld:pubmed
pubmed-article:8547337pubmed:meshHeadingpubmed-meshheading:8547337-...lld:pubmed
pubmed-article:8547337pubmed:meshHeadingpubmed-meshheading:8547337-...lld:pubmed
pubmed-article:8547337pubmed:meshHeadingpubmed-meshheading:8547337-...lld:pubmed
pubmed-article:8547337pubmed:meshHeadingpubmed-meshheading:8547337-...lld:pubmed
pubmed-article:8547337pubmed:meshHeadingpubmed-meshheading:8547337-...lld:pubmed
pubmed-article:8547337pubmed:meshHeadingpubmed-meshheading:8547337-...lld:pubmed
pubmed-article:8547337pubmed:meshHeadingpubmed-meshheading:8547337-...lld:pubmed
pubmed-article:8547337pubmed:meshHeadingpubmed-meshheading:8547337-...lld:pubmed
pubmed-article:8547337pubmed:year1996lld:pubmed
pubmed-article:8547337pubmed:articleTitleDetermination of three-dimensional solution structure of waglerin I, a toxin from Trimeresurus wagleri, using 2D-NMR and molecular dynamics simulation.lld:pubmed
pubmed-article:8547337pubmed:affiliationInstitute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.lld:pubmed
pubmed-article:8547337pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8547337pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed